Skip to main content
. 2022 Mar 29;13:1667. doi: 10.1038/s41467-022-29292-7

Fig. 1. Recommendation system takes into account diverse types of evidence to suggest promising drivers of drug resistance in NSCLC.

Fig. 1

The evidence from specially built knowledge graph, literature, clinical and pre-clinical datasets is aggregated and formalized as objectives in multi-objective optimization (MOO) task. Recommended solutions (genes) represent the optimal trade-offs between the conflicting objectives. A subset of recommended genes is passed for the experimental validation.